Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT05918094 · RECRUITING
Trial details
- NCT number
- NCT05918094
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-30
- Primary completion
- 2026-12-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.